Holen Sie sich die Stockscreener-App
0.8204
0.93%
-0.0077
Finanzdaten der Context Therapeutics Inc-Aktie (CNTX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Income/Loss |
76.49%
-9.7584
|
-5.5291 | -4.3104 | -18.70 | -3.0885 |
| Income/Loss From Continuing Operations Before Tax |
92.86%
-8.8275
|
-4.5773 | -28.96 | 1.2437 | -2.2545 |
| Income/Loss From Continuing Operations After Tax |
92.86%
-8.8275
|
-4.5773 | -3.3429 | -17.46 | -2.2545 |
Net Income/Loss
|
92.86%
-8.8275
|
-4.5773 | -3.3429 | -17.46 | -2.2545 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.00%
95.19
|
95.19 | 7.838 | 80.48 | 54.96 |
| Diluted Average Shares |
0.00%
95.19
|
95.19 | 7.838 | 80.48 | 54.96 |
| Basic Earnings Per Share |
80.00%
-0.09
|
-0.05 | - | -0.22 | -0.04 |
| Diluted Earnings Per Share |
80.00%
-0.09
|
-0.05 | - | -0.22 | -0.04 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):